Experts split sharply over experimental Alzheimer’s drug

(Charles Krupa | AP) Charles Flagg, who is stricken with Alzheimer's disease, sits for an infusion while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia.

MOST VIEWED

1

President Trump drastically shrinks 2 Utah national monuments — again

2

Utah just banned another Stephen King book from all public schools. Here’s what it’s about.

3

Sunday’s record high temp in SLC even affected air traffic

4

Viral Reckless Ben Lego videos skewer American Fork police. Here’s a look at 5 key moments.

5

First came the wildfires. Now these Utah communities are filling sandbags to brace for major flooding.

Sponsored Story

Drunken Kitchen restaurant is now open to all ages.

Sponsored: This award-winning Taiwanese & Chinese restaurant with a bold American twist is now open to families.

By Marilynn Marchione | AP Chief Medical Writer